PSN

Parsons Corporation

$60.84

+0.30%
Jun 2, 2026
Bobby Quantitative Model
Parsons Corporation is a technology-driven solutions provider operating in the defense, intelligence, and critical infrastructure markets, primarily serving the U.S. government and global clients through its Federal Solutions and Critical Infrastructure segments. The company is a significant player in the government services and engineering sector, distinguished by its focus on mission-critical projects and complex physical and digital infrastructure. The current investor narrative is dominated by a sharp stock price decline and a significant year-over-year revenue contraction, raising questions about the company's growth trajectory and the sustainability of its margins amidst what appears to be a challenging operational period.

People also watch

Parker Hannifin

Parker Hannifin

PH

Analysis
Cummins

Cummins

CMI

Analysis
Emerson Electric

Emerson Electric

EMR

Analysis
Illinois Tool Works

Illinois Tool Works

ITW

Analysis
PACCAR

PACCAR

PCAR

Analysis

BobbyInvestment Opinion: Should I buy PSN Today?

Rating: Hold. The core thesis is that Parsons is a cash-generative business in a cyclical downturn, but the stock is not yet cheap enough to discount the significant operational risks, warranting a wait-and-see approach. This aligns with the limited analyst coverage where the sole non-Buy rating is a Hold from Jefferies.

Supporting Evidence: The stock trades at a forward P/E of 16.04x, which is a discount to its trailing multiple but still requires a substantial earnings recovery to $4.21 EPS to justify. Revenue declined 7.52% YoY in Q4, and profitability is under pressure with a net margin of 3.79%. However, the strong free cash flow yield (implied by a P/CF of 13.8x) and healthy current ratio of 1.75 provide a financial cushion. The stock is 21% above its 52-week low, offering some margin of safety after a 45.41% drawdown.

Risks & Conditions: The two biggest risks are continued revenue contraction and a failure to meet forward earnings estimates, which would invalidate the forward P/E discount. This Hold would upgrade to a Buy if the stock price approaches the $48-$50 range (near the 52-week low) providing a larger margin of safety, or if QoQ revenue growth turns positive. It would downgrade to a Sell if revenue decline accelerates beyond 10% or if the forward P/E expands above 20x without corresponding earnings growth. Based on current data, the stock is fairly valued relative to its near-term challenges but undervalued relative to a successful turnaround scenario.

Sign up to view all

PSN 12-Month Price Forecast

The outlook for Parsons is one of high uncertainty balanced by a solid financial foundation. The stock is pricing in a significant earnings recovery (forward P/E of 16.04x vs. trailing 27.38x), but the recent 7.52% revenue decline provides little evidence this rebound is imminent. The strong free cash flow and bullish analyst cohort provide downside support, but the technical downtrend and fundamental weakness cap near-term upside. The stance is neutral with medium confidence, as the next 1-2 earnings reports will be critical. An upgrade to bullish would require concrete evidence of revenue stabilization and margin expansion. A downgrade to bearish would be triggered by a breakdown below the $48 support level or a further deceleration in top-line growth.

Historical Price
Current Price $60.84
Average Target $67.5
High Target $89
Low Target $48

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Parsons Corporation's 12-month outlook, with a consensus price target around $79.09 and implied upside of +30.0% versus the current price.

Average Target

$79.09

5 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

5

covering this stock

Price Range

$49 - $79

Analyst target range

Buy
1 (20%)
Hold
2 (40%)
Sell
2 (40%)

Analyst coverage is limited, with only 4 analysts providing estimates, indicating this is a mid-cap stock with lower institutional visibility. The consensus sentiment, based on recent institutional ratings, is overwhelmingly bullish, with firms like UBS, Keybanc, Truist, Barclays, and Citigroup all maintaining Buy or Overweight ratings as recently as January and February 2026, despite the stock's precipitous fall. The average target price is not provided in the data, so the implied upside cannot be calculated, but the consistent bullish stance from covering analysts suggests they see the current price weakness as a buying opportunity. The target range is also unspecified, but the high degree of unanimity among the few covering analysts (with only Jefferies at Hold) suggests a tight range and strong conviction in the long-term story, likely based on expectations for a cyclical recovery in government budgets and infrastructure spending. However, the limited number of analysts also means price discovery may be less efficient, potentially contributing to higher volatility, as seen in the stock's 45.41% maximum drawdown.

Drowning in data?

Find the real signal!

Bulls vs Bears: PSN Investment Factors

The investment debate for Parsons is a classic battle between valuation and fundamentals. The bear case, supported by concrete evidence of a 7.5% revenue decline and margin compression, currently holds stronger evidence, as the stock's price action reflects these deteriorating fundamentals. However, the bull case is anchored in analyst conviction and a forward-looking expectation of an earnings rebound, as evidenced by the large gap between trailing (27.38x) and forward (16.04x) P/E ratios. The single most important tension is whether the company's significant free cash flow generation and analyst-anticipated earnings recovery can materialize before further valuation compression occurs due to the ongoing operational weakness. The stock's 17.5% one-month rally suggests the market is beginning to price in a potential turnaround, but it remains in a deep technical downtrend.

Bullish

  • Strong Free Cash Flow Generation: Parsons generated $410.4 million in free cash flow over the trailing twelve months, providing a significant liquidity buffer. This cash generation supports the company's ability to weather operational headwinds, pay down its moderate debt, and potentially return capital to shareholders.
  • Analyst Conviction Amidst Weakness: Despite a 30.2% six-month stock decline, analyst sentiment remains overwhelmingly bullish, with firms like UBS, Keybanc, Truist, Barclays, and Citigroup maintaining Buy ratings as recently as early 2026. This suggests professional conviction in a long-term recovery story and views the price weakness as an opportunity.
  • Solid Balance Sheet & Low Beta: The company maintains a healthy current ratio of 1.75 and a moderate debt-to-equity ratio of 0.56. With a beta of 0.595, the stock has been about 40% less volatile than the market, suggesting its recent decline is driven by company-specific issues rather than broad market risk, potentially limiting downside in a market correction.
  • Forward P/E Discount to Trailing P/E: The forward P/E of 16.04x is significantly lower than the trailing P/E of 27.38x, implying the market expects a substantial earnings recovery. This expectation is supported by the analyst consensus EPS estimate of $4.21 for the coming year, which would represent a major improvement from the recent quarterly EPS of $0.52.

Bearish

  • Significant Revenue Contraction: Q4 2025 revenue of $1.60 billion declined 7.52% year-over-year, a sharp reversal from prior growth. The weakness is broad-based, with both the Federal Solutions ($784.2M) and Critical Infrastructure ($819.6M) segments showing pressure, directly challenging the core investment thesis of stable government and infrastructure demand.
  • Profitability & Margin Pressure: Net income declined sequentially from $64.1M in Q3 to $55.6M in Q4, and gross margin compressed from 22.19% to 23.03%. The trailing net margin of 3.79% is low for a technology services firm, indicating operational inefficiencies or competitive pricing pressures are eroding bottom-line results.
  • Elevated Valuation Relative to Performance: With a trailing P/E of 27.38x despite a revenue decline and margin pressure, the stock appears to carry a premium that is difficult to justify without a clear growth catalyst. This valuation disconnect increases the risk of further multiple compression if earnings do not recover as expected.
  • Persistent Long-Term Downtrend: The stock is down 30.21% over six months and 10.37% over the past year, dramatically underperforming the S&P 500's 28.21% gain. Trading at $59.1, it remains 34% below its 52-week high of $89.5, signaling sustained negative momentum and investor skepticism about the company's near-term prospects.

PSN Technical Analysis

The stock is in a pronounced downtrend, having declined 30.21% over the past six months and 10.37% over the past year, significantly underperforming the S&P 500's 28.21% gain. Currently trading at $59.1, the price sits near the lower end of its 52-week range of $48.23 to $89.5, indicating it is approximately 21% above its 52-week low. This positioning suggests the stock is in a deep correction or bear market phase, potentially offering a value entry point but also signaling persistent negative momentum and investor skepticism. Recent momentum shows a stark divergence, with a strong 17.50% gain over the past month sharply contrasting the longer-term downtrend; this could signal a potential bottoming process or a short-term relief rally within a broader bearish structure, especially given the stock's 1-month relative strength of +11.19% against the market. Key technical support is clearly defined at the 52-week low of $48.23, while resistance lies at the recent breakdown level near the 52-week high of $89.5. A sustained break below $48.23 would likely trigger further selling pressure, while a move above the recent recovery highs near $72 would be needed to suggest a trend reversal. The stock's beta of 0.595 indicates it has been about 40% less volatile than the broader market during this period, which is unusual for a stock in such a steep decline and may suggest it is less sensitive to broad market swings but driven by company-specific factors.

Beta

0.59

0.59x market volatility

Max Drawdown

-45.4%

Largest decline past year

52-Week Range

$48-$90

Price range past year

Annual Return

-3.9%

Cumulative gain past year

PeriodPSN ReturnS&P 500
1m+19.6%+5.4%
3m-7.9%+10.9%
6m-28.0%+11.0%
1y-3.9%+28.1%
ytd-2.2%+11.4%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

PSN Fundamental Analysis

Parsons' revenue trajectory is concerning, with Q4 2025 revenue of $1.60 billion representing a 7.52% year-over-year decline. Segment data shows a nearly even split, with the Federal Solutions segment contributing $784.2 million and the Critical Infrastructure segment at $819.6 million for the period, indicating the revenue weakness is broad-based. This contraction marks a significant shift from prior growth and directly challenges the investment thesis centered on stable government spending and infrastructure demand. The company remains profitable but under pressure, with Q4 net income of $55.6 million and a gross margin of 23.03%. However, profitability has weakened sequentially from Q3's net income of $64.1 million and gross margin of 22.19%, indicating margin compression. The trailing twelve-month net margin stands at 3.79%, which is low for a technology services firm and suggests operational inefficiencies or competitive pricing pressures are impacting bottom-line results. The balance sheet and cash flow position offer a mixed picture; the company maintains a healthy current ratio of 1.75 and a moderate debt-to-equity ratio of 0.56. Crucially, it generates substantial cash, with free cash flow over the trailing twelve months at $410.4 million, providing ample liquidity to fund operations, pay down debt, and potentially return capital to shareholders, which mitigates some of the near-term operational risks.

Quarterly Revenue

$1.6B

2025-12

Revenue YoY Growth

-0.07%

YoY Comparison

Gross Margin

+0.23%

Latest Quarter

Free Cash Flow

$410412000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Federal Solution Segment
Critical Infrastructure Segment

Open an Account, get $2 TSLA now!

Valuation Analysis: Is PSN Overvalued?

Given a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 27.38x, while the forward PE is significantly lower at 16.04x. This wide gap implies the market expects a substantial recovery in earnings, likely pricing in the analyst consensus EPS estimate of $4.21 for the coming year versus the most recent quarterly EPS of $0.52. Compared to sector averages, the trailing PE of 27.38x appears elevated, especially for a company experiencing revenue contraction, suggesting the stock may carry a premium based on its government-focused business model and cash flow generation, though this premium is difficult to justify without a clear growth catalyst. Historically, the current trailing PE of 27.38x is below the stock's own recent peak of 34.76x in Q2 2025 but above the low of 12.20x seen in Q4 2024, which was inflated by a one-time gain. This places the valuation in a mid-range relative to its own history, indicating the market has priced in some of the recent negative developments but not to the point of extreme pessimism seen in late 2024.

PE

27.4x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range -21x~151x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

14.2x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: The primary risk is the sustainability of the current valuation given deteriorating fundamentals. The trailing P/E of 27.38x is elevated for a company with a 7.52% revenue decline and a net margin of just 3.79%. The sequential decline in net income from $64.1M to $55.6M and gross margin pressure signal operational headwinds. While the company generates strong free cash flow ($410.4M TTM), this could be threatened if revenue contraction persists, potentially impacting its ability to service its moderate debt (D/E of 0.56) and invest for growth.

Market & Competitive Risks: The stock faces significant valuation compression risk. Its trailing P/E of 27.38x is a premium to many industrials, yet it lacks the growth to justify it, creating vulnerability to derating. The stock's low beta of 0.595 indicates its decline is company-specific, not macro-driven, highlighting execution risks. Furthermore, with revenue split nearly evenly between Federal and Critical Infrastructure segments, a slowdown in government spending or infrastructure project delays could disproportionately impact results, given the lack of a major growth engine.

Worst-Case Scenario: The worst-case scenario involves a failure to arrest the revenue decline, leading to further margin erosion and a breakdown of analyst confidence. This could trigger a re-rating to a distressed multiple, driving the stock toward its 52-week low of $48.23. A realistic downside from the current price of $59.1 is approximately -18% to this technical support level. If the company misses the forward EPS estimate of $4.21, the forward P/E premise collapses, potentially leading to a retest of the lows seen during the Q1 2024 period when the stock traded at a P/E low of 12.20x, representing a much deeper decline.

FAQ

The key risks are, in order of severity: 1) Operational Risk: Continued revenue decline (currently -7.52% YoY) and margin compression, threatening profitability. 2) Valuation Risk: The elevated trailing P/E of 27.38x could compress further if growth does not return, leading to multiple contraction. 3) Execution Risk: Failure to achieve the analyst-expected EPS of $4.21, which is pivotal to the forward P/E thesis. 4) Market Sentiment Risk: With only 4 analysts covering the stock, negative news can lead to disproportionate selling pressure, as seen in the 45.41% maximum drawdown. The company's reliance on government spending adds cyclical and budgetary risk.

The 12-month forecast for PSN is highly dependent on the company's ability to reverse its revenue trend. Our base case (55% probability) sees the stock trading between $60 and $75 as it stabilizes, supported by its forward P/E of 16x. The bull case (25% probability), driven by a successful turnaround and contract wins, could see a rally toward the $80-$89 range (near its 52-week high). The bear case (20% probability), triggered by worsening fundamentals, could see a retest of the $48-$55 support zone. The most likely scenario is the base case, which assumes the company meets lowered earnings expectations but struggles to reignite meaningful growth, resulting in range-bound trading.

PSN's valuation is bifurcated and contingent on future performance. Based on trailing earnings (P/E of 27.38x) amid a revenue contraction, the stock appears overvalued. However, based on forward earnings estimates (forward P/E of 16.04x), it appears fairly valued or slightly undervalued if the projected EPS of $4.21 is achieved. The market is currently paying a premium for past stability (trailing multiple) while discounting for future recovery (forward multiple). This creates a valuation trap if the earnings rebound fails to materialize. Compared to its own history, the current trailing P/E is in a mid-range, suggesting the market has priced in some, but not all, of the recent negative news.

PSN is a speculative buy for investors with a higher risk tolerance and a long-term horizon. The stock's appeal lies in its depressed price (down 30% in six months), strong free cash flow ($410M TTM), and unanimous bullish analyst sentiment. However, it is not a good buy for conservative investors, as it carries significant risk due to a 7.5% revenue decline and margin pressure. A purchase here is a bet that the company can meet its forward EPS estimate of $4.21 and return to growth. The current Hold rating suggests waiting for a clearer inflection point or a deeper entry price near the $48-$52 range would be prudent.

PSN is unsuitable for short-term trading due to its low beta (0.595) and company-specific, fundamental-driven price movements. It is a candidate for a long-term (3+ year) investment for investors betting on a cyclical recovery in its end markets. The stock's high volatility (45.41% drawdown) and current downtrend require a patient horizon to allow the turnaround thesis to play out. The lack of a dividend further reduces its appeal for income-focused or short-term investors. A minimum holding period of 18-24 months is suggested to evaluate whether the operational recovery implied by the forward P/E is materializing.